Breaking News, Promotions & Moves

Melinta Therapeutics Appoints Chief Technology Officer

Sunitha Lakshminarayanan offers a wealth of CMC experience across small molecules, biologics, biosimilars, vaccines, cell/gene therapy and more.

Author Image

By: Charlie Sternberg

Associate Editor

Melinta Therapeutics, LLC, a commercial-stage company providing therapies for acute and life-threatening illnesses, has appointed Sunitha Lakshminarayanan, as Chief Technology Officer, effective immediately.   Lakshminarayanan is a seasoned executive with over 20 years of experience and brings to Melinta a wealth of CMC experience across small molecules, biologics, biosimilars, vaccines, cell/gene therapy and radiotherapeutic products. Throughout her career, she has contributed to the developm...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters